<DOC>
	<DOCNO>NCT00887237</DOCNO>
	<brief_summary>Despite technological progress rate non-responders cardiac resynchronization therapy ( CRT ) remain close 30 % . This inconsistent effect CRT might due incomplete resynchronization dyssynchrony persist 25 % 30 % patient CRT . One might hypothesize stimulate ventricle single site suboptimal stimulate multiple left ventricular ( LV ) right ventricular ( RV ) sit may improve ventricular resynchronization , consequently , hemodynamic clinical effect . First study suggest 1 RV + 2 LV pace site configuration increase significantly dP/dt , pulse pressure , LV end-diastolic pressure , associate LV remodel good responder rate compare pace single LV site . First study 2 RV+LV pace site configuration demonstrate increased dP/dt cardiac output decrease cardiac dyssynchrony . The present pilot trial design examine 6-month safety biventricular stimulation 2 right ventricular ( RV ) 1 leave ventricular ( LV ) lead - main objective- ass clinical benefit .</brief_summary>
	<brief_title>Triple Site Ventricular Stimulation Cardiac Resynchronization Therapy ( CRT ) Candidates</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Signed informed consent &gt; 18 year old Cardiac resynchronization indication : New York Heart Association ( NYHA ) Class III/IV &amp; QRS width &gt; 120 m millisecond ( m ) OR NYHA class II &amp; QRS width &gt; 150 m Sinus rhythm First implant procedure Permanent ventricular tachycardia Permanent pace indication 3rd degree atrioventricular ( AV ) block Diagnosed suspect acute myocarditis Less 1 year life expectancy relate noncardiovascular disease Impossibility perform followup investigative center Pregnant woman Patient may cooperate study procedure evaluate investigator Legally protect adult patient patient unable give inform consent Patient enrol clinical trial Patient benefit social protection system Renal insufficiency Patient register heart transplant wait list Disease and/or health condition may interfere study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Cardiac resynchronization</keyword>
	<keyword>Triple site ventricular pacing</keyword>
</DOC>